A Bayesian approach for individual-level drug benefit-risk assessment

DOI10.1002/SIM.8166zbMATH Open1545.62415MaRDI QIDQ6624672FDOQ6624672

Authors: Kan Li, Sheng Luo, Sammy Yuan, Shahrul Mt-Isa 

Publication date: 28 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

MCMClatent trait modelSMAApatient centered approach

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• MCMC using Hamiltonian dynamics
• The no-U-turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo
• Dynamic Latent Trait Models for Multidimensional Longitudinal Data
• A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment
• Dynamic prediction for multiple repeated measures and event time data: an application to Parkinson's disease
• A simple way to unify multicriteria decision analysis (MCDA) and stochastic multicriteria acceptability analysis (SMAA) using a Dirichlet distribution in benefit-risk assessment

This page was built for publication: A Bayesian approach for individual-level drug benefit-risk assessment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6624672)